72nd session of the World Health Assembly :: World Health Assembly Update, 24 May 2019 :: Antimicrobial resistance

Featured Media Content

 

Editor’s Note:
The WHA continues through early next week. Below are updates selected for their relevanxce to vaccines/immunization. Next week’s edition will include additional reports on resolutions and other actions.

72nd session of the World Health Assembly
20-28 May 2019, Geneva
Main documents

World Health Assembly Update, 24 May 2019
Pandemic Influenza Preparedness Framework
Further to requests made by the World Health Assembly in 2017 and 2018, today delegates considered the final text of WHO’s analysis of the issues raised by the 2016 PIP Framework Review Group’s recommendations concerning seasonal influenza and genetic sequence data. The Health Assembly also considered the information provided by the Secretariat regarding implementation of the recommendations contained in the Director-General’s report on progress to implement decision WHA70(10).

Delegates adopted a decision to request WHO, inter alia, to work with the Global Influenza Surveillance and Response System (GISRS) and other partners to improve influenza virus sharing, and to prepare a report with Member States and stakeholders on influenza virus sharing and public health in the context of legislation and regulatory measures including those implementing the Nagoya Protocol.

Furthermore, the Health Assembly requested more information on the prototype search engine previously developed and asked WHO to explore possible next steps in raising awareness of the PIP Framework among databases, data users and data providers.

The decision also agreed to amend a footnote relating to SMTA2 (Standard Material Transfer Agreement 2) in the PIP Framework. This will help ensure that the integrity of the PIP Framework access and benefit-sharing system continues to be well maintained.

The PIP Framework is an international normative instrument adopted by the Health Assembly in 2011 that brings together WHO, Member States, industry, and other relevant stakeholders to implement a global approach to pandemic influenza preparedness and response. The objective of the PIP Framework is to ensure a fair, transparent, equitable, efficient and effective system for, on an equal footing, the sharing of influenza viruses with human pandemic potential and access to vaccines and other benefits.

Antimicrobial resistance
23 May 2019 News release Geneva
Member States at the World Health Assembly today agreed a resolution calling for continued high-level commitments to implement and adequately resource multi-sectoral National Action Plans.

The resolution urges Member States to strengthen infection prevention and control measures including water sanitation and hygiene; enhance participation in Global Antimicrobial Surveillance System; ensure prudent use of quality-assured antimicrobials; and support multisectoral annual self-assessment survey.

It requests the WHO Director-General to significantly enhance support to countries in implementing their national action plans and help mobilize needed financial resources, in collaboration with other UN agencies and partners. It also calls on the WHO Director-General to maintain the WHO list of Critically Important Antimicrobials for human medicine and keep Member States informed of WHO’s work with the other members of the Tripartite (the Food and Agriculture Organisation and the World Organisation for Animal Health) and UN agencies.

The resolution acknowledges the work of the Interagency Coordination Group on Antimicrobial Resistance to provide practical guidance to enhance global action to address antimicrobial resistance, and stresses the importance of addressing antimicrobial resistance to the achievement of the 2030 Agenda for Sustainable Development.